wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26741078-4811C2E2-7F5F-4BF0-844F-221550333E32
Q26741078-4811C2E2-7F5F-4BF0-844F-221550333E32
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26741078-4811C2E2-7F5F-4BF0-844F-221550333E32
From proprotein convertase subtilisin/kexin type 9 to its inhibition: state-of-the-art and clinical implications
P2860
Q26741078-4811C2E2-7F5F-4BF0-844F-221550333E32
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26741078-4811C2E2-7F5F-4BF0-844F-221550333E32
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6555b1f8c8c2f8f235ba0eb4bc945f506856577a
P2860
Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) randomized trial.